arrow
F

Francis Jacob

University Hospital Basel and University of Basel
H指数:30
被引数:2,858

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy

卵巢癌肿瘤谱分析资源:化疗驱动的异质性及个性化治疗策略的洞见

2026-07-130
OAAI
NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma

NKG2A抑制促进NK细胞-CD8+ T细胞相互作用以改善卵巢癌的抗肿瘤免疫

2026-04-170
OAAI
Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming

卵巢癌转移到人类大网膜会破坏器官稳态并诱导基本组织重编程

2025-12-160
OA
Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma

出版者更正:多组学肿瘤分析在指导黑色素瘤治疗中的可行性

2025-08-010
OAAI
Feasibility of multiomics tumor profiling for guiding treatment of melanoma

多组学肿瘤分析在指导黑色素瘤治疗中的可行性

2025-05-270
OA
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment

基于灌注的冷冻卵巢癌组织离体培养,保留肿瘤微环境

2025-05-230
OA
P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma

P-cadherin过表达与输卵管上皮早期转化及输卵管卵巢高级别浆液性癌的侵袭性相关

2025-05-050
OA
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia

急性髓系白血病中先天性和获得性药物耐药性的单细胞景观

2024-10-300
OAAI
Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate
2024-10-010
OAAI
Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival

输卵管卵巢高级别浆液性癌患者结局的临床与分子预测因子及特殊生存情况

2024-09-010
PRE
Redefining SOX2 as a bifunctional mediator of transcription and adjusted translation control
2024-03-220
PRE
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer

三级淋巴结构和b细胞决定卵巢癌的临床相关T细胞表型

2024-03-2113
OAAI